These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6107377)

  • 1. Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity.
    Verimer T; Goodale DB; Long JP; Flynn JR
    J Pharm Pharmacol; 1980 Sep; 32(9):665-6. PubMed ID: 6107377
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity.
    Pert A; Rosenblatt JE; Sivit C; Pert CB; Bunney WE
    Science; 1978 Jul; 201(4351):171-3. PubMed ID: 566468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers.
    Köhler U; Schröder H; Augustin W; Sabel BA
    Neurosci Lett; 1994 Mar; 170(1):99-102. PubMed ID: 8041522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain.
    Reches A; Wagner HR; Jackson V; Fahn S
    Brain Res; 1982 Aug; 246(1):172-7. PubMed ID: 6289974
    [No Abstract]   [Full Text] [Related]  

  • 8. Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.
    Gallager DW; Pert A; Bunney WE
    Nature; 1978 May; 273(5660):309-12. PubMed ID: 652037
    [No Abstract]   [Full Text] [Related]  

  • 9. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
    Lynch MR
    Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists.
    Muller P; Svensson TH; Carlsson A
    Adv Biochem Psychopharmacol; 1980; 24():69-74. PubMed ID: 6105807
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
    Bondarenko NA; Val'dman AV
    Biull Eksp Biol Med; 1989 Aug; 108(8):196-9. PubMed ID: 2553154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
    Reches A; Jackson-Lewis V; Fahn S
    Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Bloom FE
    Brain Res; 1982 Jan; 232(2):391-400. PubMed ID: 6322914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
    McIntyre IM; Kuhn C; Demitriou S; Fucek FR; Stanley M
    Psychopharmacology (Berl); 1983; 81(2):150-4. PubMed ID: 6415746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The supersensitivity of dopaminergic neurons to apomorphine in rats following chronic haloperidol.
    Vogelsang GD; Piercey MF
    Eur J Pharmacol; 1985 Apr; 110(2):267-9. PubMed ID: 3987817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic supersensitivity induced by denervation and chronic receptor blockade is additive.
    Staunton DA; Magistretti PJ; Koob GF; Shoemaker WJ; Bloom FE
    Nature; 1982 Sep; 299(5878):72-4. PubMed ID: 7110328
    [No Abstract]   [Full Text] [Related]  

  • 18. Implications of dopamine agonist-induced hypothermia following increased density of dopamine receptors in the mouse.
    Feigenbaum JJ; Yanai J
    Neuropharmacology; 1985 Aug; 24(8):735-41. PubMed ID: 3939327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of supersensitivity of pre- and postsynaptic dopamine receptors on the activity of endogenous inhibitor of cAMP dependent protein kinase in rat striatum.
    Szmigielski A; Szadowska A; Szmigielska H
    Arch Int Pharmacodyn Ther; 1984 Dec; 272(2):214-24. PubMed ID: 6098230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine.
    Gianutsos G; Moore KE
    Life Sci; 1977 May; 20(9):1585-91. PubMed ID: 875633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.